These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16796143)

  • 21. Can oral cholera vaccination play a role in controlling a cholera outbreak?
    Calain P; Chaine JP; Johnson E; Hawley ML; O'Leary MJ; Oshitani H; Chaignat CL
    Vaccine; 2004 Jun; 22(19):2444-51. PubMed ID: 15193408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy calculation in randomized trials: global or local measures?
    Emch M; Ali M; Acosta C; Yunus M; Sack DA; Clemens JD
    Health Place; 2007 Mar; 13(1):238-48. PubMed ID: 16529974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to "questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003" Vaccine 2007;25(8):1353-4.
    Thiem VD; Canh DG; Anh DD; Deen JL; von Seidlein L; Clemens JD; Holmgren J
    Vaccine; 2007 Nov; 25(47):7981-3. PubMed ID: 17933443
    [No Abstract]   [Full Text] [Related]  

  • 24. Prospects for control of cholera with oral vaccines.
    Sack RB
    J Diarrhoeal Dis Res; 1992 Mar; 10(1):1-3. PubMed ID: 1619235
    [No Abstract]   [Full Text] [Related]  

  • 25. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
    Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding.
    Ahmed T; Svennerholm AM; Al Tarique A; Sultana GN; Qadri F
    Vaccine; 2009 Feb; 27(9):1433-9. PubMed ID: 19146904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The oral cholera vaccine project; the first 3 years of field work in Bangladesh].
    van Loon FP
    Ned Tijdschr Geneeskd; 1991 Jan; 135(3):87-9. PubMed ID: 1996165
    [No Abstract]   [Full Text] [Related]  

  • 28. Cholera Control and Prevention in Bangladesh: An Evaluation of the Situation and Solutions.
    Islam MT; Clemens JD; Qadri F
    J Infect Dis; 2018 Oct; 218(suppl_3):S171-S172. PubMed ID: 30169839
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trials' limits or reunifying epidemiology.
    Idrovo AJ
    Rev Salud Publica (Bogota); 2007; 9(4):493, 494. PubMed ID: 18209815
    [No Abstract]   [Full Text] [Related]  

  • 30. Stockpiling oral cholera vaccine.
    Martin S; Costa A; Perea W
    Bull World Health Organ; 2012 Oct; 90(10):714. PubMed ID: 23109735
    [No Abstract]   [Full Text] [Related]  

  • 31. Mathematical Modeling of Endemic Cholera Transmission.
    Chao DL
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S738-S741. PubMed ID: 34550373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines on trial.
    Basu P
    Nature; 2005 Jul; 436(7050):484. PubMed ID: 16049470
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholera vaccines.
    Tacket CO; Clemens J; Kaper JB
    Biotechnology; 1992; 20():53-68. PubMed ID: 1600389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary conjoint statement on oral cholera vaccination.
    CMAJ; 1996 Oct; 155(8):1087-90. PubMed ID: 8873638
    [No Abstract]   [Full Text] [Related]  

  • 35. Cholera vaccine might work in AIDS patients.
    AIDS Policy Law; 2005 Mar; 20(5):1. PubMed ID: 15793905
    [No Abstract]   [Full Text] [Related]  

  • 36. Spatial and environmental connectivity analysis in a cholera vaccine trial.
    Emch M; Ali M; Root ED; Yunus M
    Soc Sci Med; 2009 Feb; 68(4):631-7. PubMed ID: 19135286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects.
    Peak CM; Reilly AL; Azman AS; Buckee CO
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006257. PubMed ID: 29489815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy.
    Clemens JD; Sack DA; Harris JR; Chakraborty J; Khan MR; Huda S; Ahmed F; Gomes J; Rao MR; Svennerholm AM
    J Infect Dis; 1989 Apr; 159(4):770-3. PubMed ID: 2647864
    [No Abstract]   [Full Text] [Related]  

  • 39. Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003.
    Kabir S
    Vaccine; 2007 Feb; 25(8):1353-4. PubMed ID: 17049687
    [No Abstract]   [Full Text] [Related]  

  • 40. [Perspectives on cholera vaccines].
    Valdespino-Gómez JL; Isibasi-Araujo A; Hinojosa-Ahumada MA; Giono-Cerezo S
    Salud Publica Mex; 1993; 35(1):3-19. PubMed ID: 8470019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.